Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020865

Expand all

MAXALT-MLT (RIZATRIPTAN BENZOATE)
EQ 10MG BASE
Marketing Status: Prescription
Active Ingredient: RIZATRIPTAN BENZOATE
Proprietary Name: MAXALT-MLT
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N020865
Product Number: 002
Approval Date: Jun 29, 1998
Applicant Holder Full Name: MERCK AND CO INC
Marketing Status:  Prescription
Patent and Exclusivity Information
MAXALT-MLT (RIZATRIPTAN BENZOATE)
EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Marketing Status: Discontinued
Active Ingredient: RIZATRIPTAN BENZOATE
Proprietary Name: MAXALT-MLT
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N020865
Product Number: 001
Approval Date: Jun 29, 1998
Applicant Holder Full Name: MERCK AND CO INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English